Confluence Wealth Services Inc. Buys 252 Shares of Danaher Co. (NYSE:DHR)

Confluence Wealth Services Inc. raised its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 15.6% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,864 shares of the conglomerate’s stock after acquiring an additional 252 shares during the quarter. Confluence Wealth Services Inc.’s holdings in Danaher were worth $462,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. bought a new position in Danaher during the third quarter valued at about $25,000. IAG Wealth Partners LLC grew its position in shares of Danaher by 344.8% in the second quarter. IAG Wealth Partners LLC now owns 129 shares of the conglomerate’s stock valued at $31,000 after purchasing an additional 100 shares during the last quarter. First Capital Advisors Group LLC. acquired a new stake in shares of Danaher in the second quarter valued at about $32,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at about $32,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in shares of Danaher in the third quarter valued at about $34,000. 76.71% of the stock is currently owned by institutional investors.

Danaher Stock Down 1.0 %

NYSE DHR opened at $224.58 on Thursday. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $247.62. The stock’s 50 day moving average is $222.56 and its two-hundred day moving average is $232.14. The company has a current ratio of 2.26, a quick ratio of 1.94 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $165.95 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 2.43 and a beta of 0.85.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, October 24th. The conglomerate reported $2.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.83 by $0.19. Danaher had a net margin of 20.01% and a return on equity of 13.71%. The company had revenue of $6.87 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the previous year, the company posted $2.56 earnings per share. Danaher’s quarterly revenue was down 10.3% compared to the same quarter last year. Equities analysts forecast that Danaher Co. will post 7.38 earnings per share for the current fiscal year.

Danaher Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. Wolfe Research initiated coverage on Danaher in a research report on Wednesday, December 13th. They set a “peer perform” rating on the stock. KeyCorp decreased their target price on Danaher from $300.00 to $260.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 25th. JPMorgan Chase & Co. lifted their target price on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Wells Fargo & Company decreased their target price on Danaher from $285.00 to $247.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 3rd. Finally, Raymond James decreased their target price on Danaher from $250.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $259.40.

View Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.